OBI-902, targeting TROP2, gains FDA orphan drug status for cholangiocarcinoma, a rare cancer with poor prognosis and limited treatments. Orphan drug designation provides benefits like tax credits and ...
Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced the completion ...
A nationwide ban on most hemp-derived THC products was approved by Congress last week and is scheduled to take effect late ...
4hon MSN
Chancellor to consider death row inmate's request for access to lethal injection information
Harold Wayne Nichols is to be executed Dec. 11. He's asked Gov. Bill Lee to commute his sentence to life without the ...
The baby formula company whose products have been linked to a botulism outbreak that has sickened at least 23 infants stopped ...
PRINCETON, NJ, Nov. 18, 2025 /PRNewswire/ - Medunik USA, a specialty pharmaceutical company, and part of Duchesnay ...
Regeneron is expanding its pharmaceutical production in New York, joining a wave of drug companies growing domestic ...
Manitoba’s NDP government will open the third session of the 43rd legislature today with a pledge to have a supervised drug ...
Per the Drug Safety Monitoring Board (DSMB) meeting evaluating one-third of planned participants, study to continue as planned More than half of planned participants ...
President Donald Trump said Tuesday that he was working with Indiana GOP Gov. Mike Braun to pick up two extra Republican ...
With Medicare open enrollment ending Dec. 7, beneficiaries shopping for prescription drug coverage are finding fewer options ...
19hon MSN
Tennessee judge blocks Trump's use of National Guard in Memphis but gives time for government appeal
A Tennessee judge has blocked the use of the National Guard in Memphis under a crime-fighting operation by President Donald ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback